Power Metallic Mines has declared its inaugural mineral resource estimate for the Lion Zone in Quebec, revealing a high-grade, copper-dominant deposit that holds approximately 406 million pounds of copper equivalent. With over 85% of the resource classified as indicated, the company is now positioning the site for potential development.
Regulated infrastructure provider Fuze Finance has secured approval from the Supervisory Organisation for Financial Intermediaries and Trustees to operate in Switzerland. The move marks the firm’s first expansion into Western Europe, aiming to provide institutional clients with integrated crypto-asset and stablecoin settlement alongside traditional payment rails.
With the EUDI Wallet set for a December 2026 debut, new research from IDnow reveals a significant trust gap among European users. Surveying 2,000 adults in France and Germany, the data indicates that while awareness remains low, consumers prioritize data privacy and fraud protection over mere transaction speed.
With the EUDI Wallet set for a December 2026 rollout, a new survey from IDnow reveals a significant trust gap among European users. While awareness remains low, 2,000 respondents in France and Germany suggest that adoption hinges less on convenience and more on verifiable security and granular data control.
Stepping onto the global stage during IFA 2026, Chinese display giant BOE hosted its first overseas Innovation Partner Conference in Berlin on September 7. The event gathered over 200 international partners to pivot toward the European market, anchoring its strategy in a new proprietary framework dubbed LIGHT.
Operating at temperatures significantly higher than traditional superconducting models, Fujitsu’s new diamond-spin quantum computer prototype integrates tin-vacancy centers into photonic circuits. Developed alongside Delft University of Technology and QuTech, the system represents a strategic move toward modular architectures capable of scaling to 1,000 logical qubits by 2035.
With FDA approval for its RefluxStop device now in hand, Implantica AG is turning its focus toward the American market, where an estimated 78 million people suffer from acid reflux. The company will outline its commercial rollout strategy during a Capital Markets Day gathering in Stockholm on September 9.
With FDA approval of its flagship RefluxStop device now secured, Implantica AG is turning its attention to a massive U.S. market segment where an estimated 78 million people suffer from chronic acid reflux. The company will outline its commercial rollout strategy during a Capital Markets Day in Stockholm on September 9.
The legendary boy group BIGBANG is set to bring their 2026-2027 world tour, titled , to Hong Kong this November. The three-night residency at the newly minted Kai Tak Stadium marks a high-profile return to the city for the group, which celebrates its 20th anniversary this year.
A class action lawsuit filed against ARS Pharmaceuticals claims the company misled shareholders regarding the commercialization timeline for its neffy product. Investors who purchased stock between March 9 and June 24, 2026, are now evaluating claims that the company concealed critical delays in CVS Caremark formulary coverage approvals.
A class action lawsuit now challenges Blaize Holdings, Inc. regarding claims that the company manufactured an illusion of growth by securing agreements with entities incapable of honoring them. Shareholders who acquired BZAI stock between July 18, 2025, and April 28, 2026, are currently evaluating potential legal recourse for financial losses.
Shareholders who held ARS Pharmaceuticals stock between March 9 and June 24, 2026, face an October 5 deadline to participate in a class action lawsuit. Los Angeles-based firm Schall, Brown & Schwartz LLP is currently seeking lead plaintiffs to address allegations of securities fraud involving misleading commercial guidance.
Investors who purchased Capricor Therapeutics shares between December 17, 2025, and July 26, 2026, are being urged to join a securities class action lawsuit. The litigation targets alleged violations of the Securities Exchange Act, centering on misleading public statements regarding the development of the drug Deramiocel.
Investors who purchased Rackspace Technology shares between May 7 and July 8, 2026, are facing a September 28 deadline to join a class action lawsuit. The litigation, led by Schall, Brown & Schwartz LLP, alleges the company misled shareholders regarding its financial stability and strategic pivot toward enterprise AI.
Shenzhen-based material science firm i2Cool has secured tens of millions of yuan in Series B funding led by TopoScend Capital. The company, which specializes in electricity-free passive radiative cooling technology, plans to use the capital to automate nanoparticle production lines and accelerate its expansion into global markets.
Investors who purchased Capricor Therapeutics stock between December 17, 2025, and July 26, 2026, face a September 28 deadline to join a class action lawsuit. Schall, Brown & Schwartz LLP is representing shareholders alleging the company misled the market regarding regulatory protocols for its drug, Deramiocel.
Investors who held DNOW shares as of August 5, 2025, are being recruited for a class action lawsuit alleging the company misled the market. The litigation centers on claims that DNOW downplayed integration failures linked to its merger with MRC Global Inc. and its enterprise resource planning software implementation.
Investors who purchased Pentair plc shares between April 28, 2026, and July 14, 2026, are being urged to join a class action lawsuit. The litigation alleges the company issued false and misleading statements regarding the impact of destocking in its Pool channel, concealing financial performance issues from the market.
Investors who purchased Pentair plc shares between April 28 and July 14, 2026, face an October 2 deadline to seek lead plaintiff status in a pending securities fraud lawsuit. The litigation alleges that the company misled shareholders regarding the financial impact of significant destocking within its Pool channel.
Investors who purchased Blaize Holdings, Inc. stock between July 18, 2025, and April 28, 2026, face an October 5, 2026, deadline to seek lead plaintiff status in a pending class action lawsuit. The litigation targets alleged violations of the Securities Exchange Act of 1934 regarding the company's financial reporting.
Investors who purchased Datavault AI Inc. stock between September 4, 2024, and October 30, 2025, are being recruited for a class action lawsuit. The litigation targets alleged violations of the Securities Exchange Act, claiming the company misled shareholders regarding the actual performance and trading volume of its platform.
Main Capital Partners has officially entered the UK market, acquiring a majority stake in Orgvue, a London-based specialist in Strategic Workforce Management software. The investment aims to accelerate the firm's international expansion and product development as global enterprises increasingly prioritize complex workforce modeling and optimization.
Nearly half of global manufacturers faced a cyber incident last year, prompting Rockwell Automation to launch a new season of its ROKStudios video series. Filmed at the Secure Digital Operations Forum in the UK, the episodes focus on shifting industrial security from a compliance checklist to a core business strategy.
A significant portion of the population struggles with traditional in-ear hearing devices due to anatomical constraints or physical discomfort. Addressing this gap, Flysound has introduced its B02 Open-Fit AI Hearing Aid to the U.S. market, utilizing an ear-clip design that bypasses the ear canal entirely.
Toyota has become the first automaker to adopt Autoliv’s new Human Body Model Safety Suite, a platform designed to simulate complex crash scenarios. By shifting from physical dummies to detailed digital anatomy, the system aims to provide deeper insights into injury mechanisms while accelerating vehicle development cycles.
Investors who purchased Rackspace Technology shares between May 7 and July 8, 2026, are being urged to join a class action lawsuit. The legal action alleges that the company misled shareholders by obscuring the true state of its business operations while aggressively pivoting toward artificial intelligence investments.
Shareholders who purchased Wise Group plc stock between May 11 and July 23, 2026, face a September 28 deadline to seek lead plaintiff status in a pending class action lawsuit. The litigation targets alleged violations of federal securities laws stemming from the company's failure to maintain adequate anti-money laundering controls.
A specialized charter flight carrying air-to-air missiles arrived at Incheon International Airport from France this week, marking the completion of a high-security defense logistics mission. The cargo, destined for the Republic of Korea Marine Corps' attack helicopter program, required complex international clearance across 14 separate nations.
Investors who purchased EquipmentShare.com Inc. stock between January 23 and June 23, 2026, face a looming September 21 deadline to join a class action lawsuit. The litigation centers on claims that the company misled the market by failing to disclose persistent related-party transactions during the specified period.
With 650 industry professionals gathering in Singapore for the Asia Bio Partnering Forum 2026, South Korea’s GCCL leveraged its position as a Platinum Sponsor to deepen ties with global drug developers and expand its reach in the clinical trial sample analysis sector across the Asia-Pacific region.
